Cocrystal PharmaCOCP
13F holders, Q3 2025 (September 30)22holders
4new positions
3sold out
1famous investor
$1.25avg. 13F price*
At the end of Q3 2025, 22 institutions reported holding Cocrystal Pharma Inc. (COCP) in their 13F filings, unchanged from Q2 2025. 4 opened new positions and 3 sold out. The largest holders were Vanguard Group Inc. ($335K), Renaissance Technologies ($160K) and Geode Capital Management, LLC ($92K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Cocrystal Pharma Inc.
- CUSIP
- 19188J409
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $67K |
| Exits | 3 | $82K |
All 13F filers, Q2 2025 → Q3 2025: 57,729 shares bought and 79,262 shares sold, net −21,533 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 22 holders
| Vanguard Group Inc. | 0.00% | No change | 268,080 | $335K |
| Renaissance Technologies | 0.00% | Add +2.3% | 127,928 | $160K |
| Geode Capital Management, LLC | 0.00% | Add +1.1% | 73,929 | $92K |
| BlackRock, Inc. | 0.00% | No change | 73,746 | $92K |
| Neuberger Berman Group LLC | 0.00% | New | 31,886 | $40K |
| Jane Street Group, LLC | 0.00% | New | 21,044 | $26K |
| State Street Corp. | 0.00% | No change | 20,543 | $26K |
| Parallel Advisors, LLC | 0.00% | Reduce -17.2% | 12,611 | $16K |
| Northern Trust Corp. | 0.00% | No change | 11,921 | $15K |
| Bank of America Corp. | 0.00% | Reduce -0.1% | 9,092 | $11K |
| Morgan Stanley | 0.00% | No change | 5,863 | $7K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -10.0% | 3,298 | $4K |
| Wells Fargo & Company | 0.00% | No change | 1,812 | $2K |
| Citigroup Inc. | 0.00% | New | 1,053 | $1K |
| Northwestern Mutual Wealth Management Co. | 0.00% | No change | 817 | $1K |
| UBS Group AG | 0.00% | Reduce -97.4% | 571 | $714 |
| Clean Yield Group | 0.00% | No change | 418 | $523 |
| MAI Capital Management | 0.00% | No change | 237 | $297 |
| Nvwm, LLC | 0.00% | No change | 84 | $105 |
| SBI Securities Co., Ltd. | 0.00% | Add +3.0% | 34 | $43 |
| Barclays PLC | 0.00% | New | 16 | $20 |
| Royal Bank of Canada | 0.00% | No change | 51 | $0 |
"% of holder's portfolio" is COCP's weight in each manager's 13F, not the share of Cocrystal Pharma Inc. the manager owns.